iRhythm Holdings, Inc. (IRTC): R&D Expense
$84.61M
Year ended 2025-12-31
$83.28M
Trailing 12 months to 2026-06-30
+22.0%
3-year compound annual growth
+15.4%
5-year compound annual growth
+29.6%
10-year compound annual growth
| Period ended | R&D Expense | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $84.61M | +18.4% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $71.46M | +18.6% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $60.24M | +29.3% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $46.61M | +20.5% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | $38.67M | -6.4% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | $41.33M | +10.8% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $37.30M | +78.8% | 2022-02-28, From 2019-01-01 |
| 2018-12-31 | $20.86M | +57.3% | 2021-02-26, From 2018-01-01 |
| 2017-12-31 | $13.27M | +85.5% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $7.15M | +12.6% | 2019-03-04, From 2016-01-01 |
| 2015-12-31 | $6.35M | +11.4% | 2018-03-01, From 2015-01-01 |
| 2014-12-31 | $5.70M | n/a | 2017-03-31, From 2014-01-01 |
R&D Expense at similar companies
| Company | Year ended | R&D Expense | Change YoY |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | 2025-12-31 | $84.61M | +18.4% |
| Alphatec Holdings, Inc. (ATEC) | 2025-12-31 | $76.27M | -5.5% |
| Orthofix Medical Inc. (OFIX) | 2025-12-31 | $65.85M | -10.6% |
| NovoCure Ltd (NVCR) | 2025-12-31 | $224.54M | +7.1% |
| Inspire Medical Systems, Inc. (INSP) | 2025-12-31 | $103.17M | -9.6% |
| UFP Technologies Inc (UFPT) | 2025-12-31 | $8.60M | -17.3% |
| Bioventus Inc. (BVS) | 2025-12-31 | $12.11M | -13.2% |
| Tandem Diabetes Care Inc (TNDM) | 2025-12-31 | $193.11M | -2.9% |
| AtriCure, Inc. (ATRC) | 2025-12-31 | $99.21M | +3.2% |
Compare IRTC, ATEC, OFIX, NVCR side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗